Tamás Molnár (Tamas Molnar)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 34

Top Topics

Low Density Lipoprotein

Systematic Review

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Top Venues

The American journal of gastroenterology

Therapeutic advances in gastroenterology

Expert opinion on biological therapy

Journal of Crohn's & colitis

This page only lists publications with an associated author ORCID identifier.

Publications

Péter Bacsur, Panu Wetwittayakhlang, Tamás Resál, Emese Földi, Béla Vasas, Bernadett Farkas, Mariann Rutka, Talat Bessissow, Waqqas Afif, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, Klaudia Farkas, Peter L Lakatos, Tamás Molnár
Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system. Therapeutic advances in gastroenterology 17 (2024)
Gabriele Dragoni, Tommaso Innocenti, Aurélien Amiot, Fabiana Castiglione, Laura Melotti, Stefano Festa, Edoardo Vincenzo Savarino, Marie Truyens, Konstantinos Argyriou, Daniele Noviello, Tamás Molnár, Vincent Bouillon, Cristina Bezzio, Piotr Eder, Samuel Raimundo Fernandes, Anna Kagramanova, Alessandro Armuzzi, Raquel Oliveira, Anna Viola, Davide Giuseppe Ribaldone, Ioannis Drygiannakis, Chiara Viganò, Francesca Calella, Antonietta Gerarda Gravina, Daniela Pugliese, Maria Chaparro, Pierre Ellul, Sophie Vieujean, Monica Milla, Flavio Andrea Caprioli, null null
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study. The American journal of gastroenterology (2024)
Péter Bacsur, Panu Wetwittayakhlang, Tamás Resál, Emese Földi, Béla Vasas, Bernadett Farkas, Mariann Rutka, Talat Bessissow, Waqqas Afif, Anita Bálint, Anna Fábián, Renáta Bor, Zoltán Szepes, Klaudia Farkas, Peter L Lakatos, Tamás Molnár
Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system. Therapeutic advances in gastroenterology 17 (2024)
Gabriele Dragoni, Tommaso Innocenti, Aurélien Amiot, Fabiana Castiglione, Laura Melotti, Stefano Festa, Edoardo Vincenzo Savarino, Marie Truyens, Konstantinos Argyriou, Daniele Noviello, Tamás Molnár, Vincent Bouillon, Cristina Bezzio, Piotr Eder, Samuel Raimundo Fernandes, Anna Kagramanova, Alessandro Armuzzi, Raquel Oliveira, Anna Viola, Davide Giuseppe Ribaldone, Ioannis Drygiannakis, Chiara Viganò, Francesca Calella, Antonietta Gerarda Gravina, Daniela Pugliese, Maria Chaparro, Pierre Ellul, Sophie Vieujean, Monica Milla, Flavio Andrea Caprioli, null null
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study. The American journal of gastroenterology (2024)
Gabriele Dragoni, Tommaso Innocenti, Aurélien Amiot, Fabiana Castiglione, Laura Melotti, Stefano Festa, Edoardo Vincenzo Savarino, Marie Truyens, Konstantinos Argyriou, Daniele Noviello, Tamás Molnár, Vincent Bouillon, Cristina Bezzio, Piotr Eder, Samuel Raimundo Fernandes, Anna Kagramanova, Alessandro Armuzzi, Raquel Oliveira, Anna Viola, Davide Giuseppe Ribaldone, Ioannis Drygiannakis, Chiara Viganò, Francesca Calella, Antonietta Gerarda Gravina, Daniela Pugliese, Maria Chaparro, Pierre Ellul, Sophie Vieujean, Monica Milla, Flavio Andrea Caprioli, null null
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study. The American journal of gastroenterology (2024)
Gabriele Dragoni, Tommaso Innocenti, Aurélien Amiot, Fabiana Castiglione, Laura Melotti, Stefano Festa, Edoardo Vincenzo Savarino, Marie Truyens, Konstantinos Argyriou, Daniele Noviello, Tamás Molnár, Vincent Bouillon, Cristina Bezzio, Piotr Eder, Samuel Raimundo Fernandes, Anna Kagramanova, Alessandro Armuzzi, Raquel Oliveira, Anna Viola, Davide Giuseppe Ribaldone, Ioannis Drygiannakis, Chiara Viganò, Francesca Calella, Antonietta Gerarda Gravina, Daniela Pugliese, Maria Chaparro, Pierre Ellul, Sophie Vieujean, Monica Milla, Flavio Andrea Caprioli, null null
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study. The American journal of gastroenterology (2024)
Bernadett Farkas, Emese Ivány, Anita Bálint, Péter Bacsur, Tamás Molnár, Klaudia Farkas
Diagnostic and Therapeutic Challenges in Severe Peristomal Pyoderma Gangrenosum. Inflammatory bowel diseases (2024)
Gabriele Dragoni, Tommaso Innocenti, Aurélien Amiot, Fabiana Castiglione, Laura Melotti, Stefano Festa, Edoardo Vincenzo Savarino, Marie Truyens, Konstantinos Argyriou, Daniele Noviello, Tamás Molnár, Vincent Bouillon, Cristina Bezzio, Piotr Eder, Samuel Raimundo Fernandes, Anna Kagramanova, Alessandro Armuzzi, Raquel Oliveira, Anna Viola, Davide Giuseppe Ribaldone, Ioannis Drygiannakis, Chiara Viganò, Francesca Calella, Antonietta Gerarda Gravina, Daniela Pugliese, Maria Chaparro, Pierre Ellul, Sophie Vieujean, Monica Milla, Flavio Andrea Caprioli, null null
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study. The American journal of gastroenterology (2024)
Barbara Horvát, Kata Orbán, Anett Dávid, Viola Sallay, Beatrix Rafael, Sanela Njers, Tamás Molnár, Márta Csabai, Georgina Csordás, Tamás Martos
Enhancing self-management of patients with inflammatory bowel disease: the role of autonomy support in health goal pursuit. Therapeutic advances in gastroenterology 17 (2024)
Gabriele Dragoni, Tommaso Innocenti, Aurélien Amiot, Fabiana Castiglione, Laura Melotti, Stefano Festa, Edoardo Vincenzo Savarino, Marie Truyens, Konstantinos Argyriou, Daniele Noviello, Tamás Molnár, Vincent Bouillon, Cristina Bezzio, Piotr Eder, Samuel Raimundo Fernandes, Anna Kagramanova, Alessandro Armuzzi, Raquel Oliveira, Anna Viola, Davide Giuseppe Ribaldone, Ioannis Drygiannakis, Chiara Viganò, Francesca Calella, Antonietta Gerarda Gravina, Daniela Pugliese, Maria Chaparro, Pierre Ellul, Sophie Vieujean, Monica Milla, Flavio Andrea Caprioli, null null
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study. The American journal of gastroenterology 119 (8) (2024)
Gabriele Dragoni, Tommaso Innocenti, Aurélien Amiot, Fabiana Castiglione, Laura Melotti, Stefano Festa, Edoardo Vincenzo Savarino, Marie Truyens, Konstantinos Argyriou, Daniele Noviello, Tamás Molnár, Vincent Bouillon, Cristina Bezzio, Piotr Eder, Samuel Raimundo Fernandes, Anna Kagramanova, Alessandro Armuzzi, Raquel Oliveira, Anna Viola, Davide Giuseppe Ribaldone, Ioannis Drygiannakis, Chiara Viganò, Francesca Calella, Antonietta Gerarda Gravina, Daniela Pugliese, Maria Chaparro, Pierre Ellul, Sophie Vieujean, Monica Milla, Flavio Andrea Caprioli, null null
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study. The American journal of gastroenterology (2024)
Gabriele Dragoni, Tommaso Innocenti, Aurélien Amiot, Fabiana Castiglione, Laura Melotti, Stefano Festa, Edoardo Vincenzo Savarino, Marie Truyens, Konstantinos Argyriou, Daniele Noviello, Tamás Molnár, Vincent Bouillon, Cristina Bezzio, Piotr Eder, Samuel Raimundo Fernandes, Anna Kagramanova, Alessandro Armuzzi, Raquel Oliveira, Anna Viola, Davide Giuseppe Ribaldone, Ioannis Drygiannakis, Chiara Viganò, Francesca Calella, Antonietta Gerarda Gravina, Daniela Pugliese, Maria Chaparro, Pierre Ellul, Sophie Vieujean, Monica Milla, Flavio Andrea Caprioli, null null
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study. The American journal of gastroenterology (2024)
Gabriele Dragoni, Tommaso Innocenti, Aurélien Amiot, Fabiana Castiglione, Laura Melotti, Stefano Festa, Edoardo Vincenzo Savarino, Marie Truyens, Konstantinos Argyriou, Daniele Noviello, Tamás Molnár, Vincent Bouillon, Cristina Bezzio, Piotr Eder, Samuel Raimundo Fernandes, Anna Kagramanova, Alessandro Armuzzi, Raquel Oliveira, Anna Viola, Davide Giuseppe Ribaldone, Ioannis Drygiannakis, Chiara Viganò, Francesca Calella, Antonietta Gerarda Gravina, Daniela Pugliese, Maria Chaparro, Pierre Ellul, Sophie Vieujean, Monica Milla, Flavio Andrea Caprioli, null null
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study. The American journal of gastroenterology (2024)
Péter Bacsur, Ákos Iliás, Tamás Resál, Diána Kata, Tamás Molnár, Klaudia Farkas
Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary. Alimentary pharmacology & therapeutics 58 (2) (2023)
Séverine Vermeire, Jurij Hanzel, Mark Löwenberg, Marc Ferrante, Peter Bossuyt, Frank Hoentjen, Denis Franchimont, Károly Palatka, Harald Peeters, Aart Mookhoek, Gert de Hertogh, Tamás Molnár, Wouter van Moerkercke, Triana Lobatón, Esmé Clasquin, Melanie S Hulshoff, Filip Baert, Geert D'Haens, null null
Early versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes. Journal of Crohn's & colitis (2023)
Tamás Resál, Katalin Mangó, Péter Bacsur, Kata Judit Szántó, Daniella Pigniczki, Csilla Keresztes, Mariann Rutka, Anita Bálint, Ágnes Milassin, Renáta Bor, Anna Fábián, Zoltán Szepes, Klaudia Farkas, Katalin Monostory, Tamás Molnár
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone. Expert opinion on drug safety (2023)
Anett Dávid, Márta Volosin, Klaudia Farkas, Tamás Resál, Csilla Keresztes, Beatrix Rafael, Tamás Molnár
Burnout among European IBD specialists: a survey supported by ECCO. Therapeutic advances in gastroenterology 16 (2023)
Patricia Sarlos, Alexander Bikar, Nelli Farkas, Tamás Resál, Zoltán Szepes, Klaudia Farkas, Ferenc Nagy, Áron Vincze, Pal Miheller, Tamás Molnár
Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease: results of a multicenter survey. Expert opinion on biological therapy (2023)
Tamás Resál, Péter Bacsur, Csilla Keresztes, Anita Bálint, Renáta Bor, Anna Fábián, Bernadett Farkas, Kostas Katsanos, George Michalopoylos, Davide Giuseppe Ribaldone, Mohamed Attauabi, Mirabella Zhao, Hadar Amir Barak, Henit Yanai, Cristina Bezzio, Antonio Rispo, Fabiana Castiglione, Ariella Bar-Gil Shitrit, Daniela Pugliese, Alessandro Armuzzi, Edoardo Vincenzo Savarino, Martin Kolar, Milan Lukáš, Elena Chashkova, Rafał Filip, Aurore Rozieres, Stéphane Nancey, Željko Krznarić, Eszter Schäfer, null Szamosi, Patrícia Sarlós, Matej Franko, David Drobne, Oleg V Knyazev, Anna V Kagramanova, Jimmy Limdi, Panu Wetwittayakhlang, Peter L Lakatos, Nitsan Maharshak, Lian Bannon, Tibor Nyári, Zoltán Szepes, Klaudia Farkas, null null, Tamás Molnár
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study. Inflammatory bowel diseases (2023)
Tamás Resál, Katalin Mangó, Péter Bacsur, Kata Judit Szántó, Daniella Pigniczki, Csilla Keresztes, Mariann Rutka, Anita Bálint, Ágnes Milassin, Renáta Bor, Anna Fábián, Zoltán Szepes, Klaudia Farkas, Katalin Monostory, Tamás Molnár
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone. Expert opinion on drug safety (2023)
Boldizsár Jójárt, Tamás Resál, Diána Kata, Tünde Molnár, Péter Bacsur, Viktória Szabó, Árpád Varga, Kata Judit Szántó, Petra Pallagi, Imre Földesi, Tamás Molnár, József Maléth, Klaudia Farkas
Plasminogen activator inhibitor 1 is a novel faecal biomarker for monitoring disease activity and therapeutic response in inflammatory bowel diseases. Journal of Crohn's & colitis (2023)
Hannah Gordon, Livia Biancone, Gionata Fiorino, Konstantinos H Katsanos, Uri Kopylov, Eman Al Sulais, Jordan E Axelrad, Karthiha Balendran, Burisch J, Lissy de Ridder, Lauranne Derikx, Pierre Ellul, Thomas Greuter, Marietta Iacucci, Caroline Di Jiang, Christina Kapizioni, Konstantinos Karmiris, Julien Kirchgesner, David Laharie, Triana Lobatón Ortega, Tamás Molnár, Nurulamin M Noor, Rohit Rao, Simone Saibeni, Michael Scharl, Stephan R Vavricka, Timothy Raine
ECCO Guidelines on Inflammatory Bowel Disease and Malignancies. Journal of Crohn's & colitis (2022)
Tamás Resál, Renáta Bor, Kata Judit Szántó, Anna Fábián, Mariann Rutka, Marco Sacco, Davide Guiseppe Ribaldone, Pauliina Molander, Stephane Nancey, Uri Kopylov, Stephan Vavricka, David Drobne, Milan Lukas, Klaudia Farkas, Zoltán Szepes, Tamás Molnár
Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey. Therapeutic advances in gastroenterology 14 (2021)
Jasmijn A M Sleutjes, Jeanine E Roeters van Lennep, Eric Boersma, Luis A Menchen, Matthias Laudes, Klaudia Farkas, Tamás Molnár, Nicholas Alexander Kennedy, Marieke J Pierik, Christien J van der Woude, Annemarie C de Vries
Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels. Alimentary pharmacology & therapeutics 54 (8) (2021)
Klaudia Farkas, Daniella Pigniczki, Mariann Rutka, Kata Judit Szántó, Tamás Resál, Renáta Bor, Anna Fábián, Zoltán Szepes, György Lázár, Tamás Molnár
The complex relationship between viruses and inflammatory bowel disease - review and practical advices for the daily clinical decision-making during the SARS-CoV-2 pandemic. Therapeutic advances in gastroenterology 14 (2021)
Kata Judit Szántó, Tamara Madácsy, Diána Kata, Tamás Ferenci, Mariann Rutka, Anita Bálint, Renáta Bor, Anna Fábián, Ágnes Csontos, Boldizsár Jójárt, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Imre Földesi, József Maléth, Klaudia Farkas
Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists. Expert opinion on biological therapy 21 (4) (2021)
Kata Judit Szántó, Tamás Balázs, Dóra Mihonné Schrempf, Klaudia Farkas, Tamás Molnár
Does inflammatory bowel disease have different characteristics according to stage of adolescence? Therapeutic advances in gastroenterology 14 (2021)
Péter Kunovszki, Kata Judit Szántó, Judit Gimesi-Országh, Péter Takács, Andras Borsi, Anita Bálint, Klaudia Farkas, Ágnes Csontos, Péter L Lakatos, Tamás Szamosi, Tamás Molnár
Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016. Expert opinion on biological therapy 20 (4) (2020)
Mariann Rutka, Renáta Bor, Tamás Molnár, Klaudia Farkas, Daniella Pigniczki, Anna Fábián, Márk Györffy, Anita Bálint, Ágnes Csontos, Mónika Szücs, László Tiszlavicz, Ferenc Nagy, Zoltán Szepes
Efficacy of the population-based pilot colorectal cancer screening, Csongrád county, Hungary, 2015 Turkish journal of medical sciences 50 (4) (2020)
Renáta Bor, Béla Vasas, Anna Fábián, Mónika Szücs, Árpád Füredi, László Czakó, Mariann Rutka, Klaudia Farkas, Tamás Molnár, Ágnes Csontos, Anita Bálint, Kata Judit Szántó, Sándor Hamar, László Kaizer, László Tiszlavicz, Zoltán Szepes
Slow-pull technique yields better quality smears: prospective comparison of slow-pull and standard suction techniques of endoscopic ultrasound-guided fine-needle aspiration. Scandinavian journal of gastroenterology 55 (11) (2020)
Renáta Bor, Anna Fábián, Klaudia Farkas, Tamás Molnár, Zoltán Szepes
Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn's disease - review of pathomechanism and existing clinical data. Expert opinion on biological therapy 18 (7) (2018)
Anna Fábián, Mariann Rutka, Tamás Ferenci, Renáta Bor, Anita Bálint, Klaudia Farkas, Ágnes Milassin, Kata Szántó, Zsuzsanna Lénárt, Ferenc Nagy, Zoltán Szepes, Tamás Molnár
The Use of Complementary and Alternative Medicine Is Less Frequent in Patients with Inflammatory Bowel Disease Than in Patients with Other Chronic Gastrointestinal Disorders. Gastroenterology research and practice 2018 (2018)
Fanni Rencz, Peter Laszlo Lakatos, László Gulácsi, Valentin Brodszky, Zsuzsanna Kürti, Szilvia Lovas, János Banai, László Herszényi, Tamás Cserni, Tamás Molnár, Márta Péntek, Károly Palatka
Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 28 (1) (2018)
Klaudia Farkas, Mariann Rutka, Tamás Ferenci, Ferenc Nagy, Anita Bálint, Renáta Bor, Ágnes Csontos, Anna Fábián, Kata Szántó, Zsuzsanna Végh, Zsuzsanna Kürti, Péter L Lakatos, Zoltán Szepes, Tamás Molnár
Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center. Expert opinion on biological therapy 17 (11) (2017)